Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Endocet (oxycodone-acetaminophen) Treatment Report
What is Endocet?

Endocet® is a brand name for the combination of oxycodone, an opioid analgesic and acetaminophen, a non-steroidal anti-inflammatory drug. It is used for the management of moderate to severe pain.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Pain 4 2
burning pain 2 0
shoulder/neck/back/hip pain 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
1 50%
Mild
1 50%
None
0 0%

Most commonly reported side effects

Constipation
2 100%
light headed
1 50%
Dizziness
1 50%
  • Mild
  • Moderate
  • Severe

Dosages

  325mg-10mg as needed 325mg-5mg as needed 500mg-7.5mg as needed 325 mg-5 mg daily 4 x 500 mg-7.5 mg daily 8 x 325 mg-5 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Endocet (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other
1 100% Other: 100%

See all 1 patient who’ve stopped taking Endocet

Duration See details about how long patients take this treatment ▼

Currently Taking Endocet

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
2
0
1
1
1

Stopped Taking Endocet

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
2 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
1 50%
A little
0 0%
Not at all
1 50%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
1 50%
< $25
1 50%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.